{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"FibroBiologics Announces Payoff of Outstanding Debt - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"p32Q9n6NtW\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-announces-payoff-of-outstanding-debt\/\">FibroBiologics Announces Payoff of Outstanding Debt<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-announces-payoff-of-outstanding-debt\/embed\/#?secret=p32Q9n6NtW\" width=\"600\" height=\"338\" title=\"&#8220;FibroBiologics Announces Payoff of Outstanding Debt&#8221; &#8212; Market Newsdesk\" data-secret=\"p32Q9n6NtW\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Repayment of convertible promissory notes strengthens balance sheet and eliminates further dilution from conversions HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it has paid all amounts outstanding under the convertible promissory notes (the \u201cNotes\u201d) issued to YA II PN, Ltd. (&#8220;Yorkville&#8221;), an investment fund managed by Yorkville Advisors Global, LP, pursuant to the Standby Equity Purchase Agreement (\u201cSEPA\u201d) entered into on December 20, 2024 between the Company and Yorkville. The SEPA allows the Company, subject to customary conditions, to sell &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjU0MSM3MjkzNDk0IzIyNjM1MzE="}